VEGF Trap

Related by string. * : VEGF Trap Eye . VEGF receptor tyrosine kinases . VEGF Vascular Endothelial Growth . inhibiting VEGF Avastin . factor VEGF . anti VEGF . VEGF receptors . VEGF vascular endothelial / TRAP . TRAPS . Traps . traps . trap : crab traps . crab trap . lobster traps . Temper Trap . gravel trap . offside trap . Wolf Trap * aflibercept VEGF Trap . evaluating VEGF Trap . Aflibercept VEGF Trap *

Related by context. All words. (Click for frequent words.) 70 aflibercept 70 JAK inhibitor 70 BAY #-# 68 ocrelizumab 68 Phase Ib 67 PSN# [002] 67 PEG SN# 67 Onconase 67 docetaxel Taxotere R 67 T DM1 66 neratinib 66 HuMax EGFr 66 Aflibercept 66 dacetuzumab 66 anti angiogenic agent 66 Azedra 66 Nexavar sorafenib 66 AP# [003] 66 Mipomersen 66 Phase IIa trials 66 Nexavar ® 66 JAK3 inhibitor 66 Litx 66 INCB# [001] 66 elotuzumab 66 Amrubicin 66 PSMA ADC 66 CoFactor 65 volociximab 65 angiogenesis inhibitor 65 TELINTRA 65 AEG# 65 rNAPc2 65 Sym# 65 Dasatinib 65 ganetespib 65 proteasome inhibitor 65 Aplidin 65 EndoTAG TM -1 65 Allovectin 7 65 axitinib 65 IL# PE#QQR 65 Celgene Revlimid 65 HuLuc# 65 investigational monoclonal antibody 65 eniluracil 65 OncoVEX 65 nalbuphine ER 65 PLK1 SNALP 65 Dacogen injection 65 Panzem 65 phase IIb 65 Targretin 65 phase IIb clinical 65 YONDELIS 65 glufosfamide 65 methylnaltrexone 65 mertansine 65 Fodosine 65 ixabepilone 65 Civacir 65 VEGF Trap Eye 65 Genentech Roche 65 Velcade bortezomib 65 Vitaxin 65 HGS# 65 pertuzumab 65 carfilzomib 65 GALNS 65 PDE4 inhibitor 65 TACI Ig 65 HuMax CD4 64 Cloretazine R VNP#M 64 MEK inhibitor 64 sunitinib malate 64 histone deacetylase HDAC inhibitor 64 enzastaurin 64 teduglutide 64 Vandetanib 64 dirucotide 64 tanespimycin 64 Bicifadine 64 Squalamine 64 Taxotere docetaxel 64 vidofludimus 64 oral prodrug 64 L BLP# 64 squalamine 64 TRISENOX 64 CA4P 64 deforolimus 64 PRT# 64 ISIS # 64 Onrigin 64 ridaforolimus 64 Lucentis ranibizumab 64 Factor VIIa 64 SAR# [004] 64 Hycamtin 64 Corlux 64 CR# vcMMAE 64 GLPG# 64 Dalbavancin 64 Tarceva TM 64 EndoTAG 64 LAF# 64 REOLYSIN ® 64 Pertuzumab 64 Arcalyst 64 HuMax CD# 64 Zolinza 64 Immunotherapeutic 64 Avastin bevacizumab 64 bortezomib Velcade 64 Phase III clinical 64 ASONEP 64 PREOS R 64 Allovectin 7 ® 64 antisense drug 64 Glufosfamide 64 PEG Interferon lambda 64 RNAi therapeutic targeting 64 MAXY G# 64 FTY# 64 Asentar 64 Clolar ® 64 Phase IIa 64 Oncaspar 64 HCD# [002] 64 Nanobody 64 Tasimelteon 64 Marqibo 64 Icatibant 64 trastuzumab DM1 T DM1 63 induced macular edema 63 PXD# 63 Desmoteplase 63 Plicera 63 atacicept 63 KNS # 63 dexpramipexole 63 Nexavar 63 Ceflatonin 63 CCX# 63 LY# [003] 63 metaglidasen 63 Tezampanel 63 bevacizumab Avastin 63 synthetic retinoid 63 Advexin 63 Vidaza azacitidine 63 lintuzumab 63 sapacitabine 63 Phase 1b 63 Phenoptin 63 INS# [001] 63 ALN TTR# 63 cilengitide 63 Panzem R NCD 63 phase IIa clinical 63 rituximab Rituxan 63 TG# [003] 63 investigational humanized monoclonal antibody 63 omacetaxine 63 ProSavin 63 Tarceva erlotinib 63 Carfilzomib 63 cediranib 63 cannabinor 63 kinase inhibitors 63 Zadaxin 63 ATL# [001] 63 alvespimycin 63 HDAC Inhibitor 63 Vilazodone 63 paclitaxel Taxol ® 63 Archexin 63 Mepact 63 Telaprevir 63 Xelox 63 Pfizer Sutent 63 octreotide implant 63 BLP# Liposome Vaccine 63 registrational 63 MOZOBIL 63 docetaxel Taxotere ® 63 R#/MEM # 63 Golimumab 63 huC# DM4 63 JAK2 inhibitor 63 celgosivir 63 Firazyr 63 sorafenib Nexavar 63 phase IIa 63 Leukine 63 Phase IIIb clinical 63 Onyx Pharma 63 Leukine ® 63 immunotherapeutic agent 63 gefitinib Iressa 63 Tamibarotene 63 subcutaneous formulation 63 CINTREDEKIN BESUDOTOX 63 TKM ApoB 63 Xanafide 63 pomalidomide 63 AQ4N 63 HCV protease inhibitor 63 ApoB SNALP 63 AeroLEF TM 63 Alocrest 63 iSONEP 62 Abiraterone acetate 62 Ozurdex 62 erlotinib Tarceva 62 Cloretazine ® 62 iniparib 62 OHR/AVR# 62 Tarvacin 62 Onco TCS 62 Quinamed 62 Daclizumab 62 pemetrexed Alimta 62 preclinical 62 lumiliximab 62 IMGN# 62 Phase Ib II 62 eltrombopag 62 Octreotide 62 Santhera 62 corticosteroid dexamethasone 62 metastatic hormone refractory 62 Omacetaxine 62 AzaSite Plus 62 liposomal formulation 62 IAP inhibitors 62 Canvaxin 62 Ridaforolimus 62 Phase Ib clinical 62 FOLOTYN ® 62 oral antiviral 62 PEP# [003] 62 Maribavir 62 Phase #b/#a 62 clofarabine 62 Mozobil 62 BRAF inhibitor 62 reslizumab 62 Aryplase 62 Numax 62 CBLC# 62 PROMACTA 62 otelixizumab 62 anti angiogenic agents 62 bevasiranib 62 PRX # 62 Troxatyl 62 Vicriviroc 62 Elotuzumab 62 Viprinex 62 Tesetaxel 62 sorafenib tablets 62 CDP# 62 Xcellerated T Cells 62 Trastuzumab 62 RG# [001] 62 Ixabepilone 62 Panitumumab 62 BrachySil TM 62 Bezielle 62 anticancer agent 62 Dapagliflozin 62 Zybrestat 62 Neulasta ® 62 Synavive 62 PF # [001] 62 selective androgen receptor modulator 62 Safinamide 62 targeted radiotherapeutic 62 Cardio Vascu Grow 62 obatoclax 62 atrasentan 62 tafamidis 62 proteasome inhibitor bortezomib 62 sargramostim 62 HQK 62 GRN#L 62 Trofex 62 placebo controlled Phase 62 Phase IIb clinical trials 62 aleglitazar 62 GW# [003] 62 Bevacizumab 62 Cloretazine R 62 Tykerb lapatinib 62 incyclinide 62 ASA# 62 EVIZON 62 Herceptin trastuzumab 62 adecatumumab 62 CEQ# 62 fenretinide 62 daclizumab 62 LEUKINE 62 mipomersen 62 evaluating satraplatin 62 ZK EPO 62 TREANDA 62 ELACYT 62 brivaracetam 62 Erbitux cetuximab 62 rilonacept 62 teriflunomide 62 antibody MAb 62 Ixempra 61 Rescula 61 preclinical efficacy 61 HGS ETR2 61 Zerenex 61 NVA# 61 IMA# 61 VEGF inhibitor 61 ZOLINZA 61 Aurora kinase inhibitor 61 REP# 61 PLX# 61 Actemra 61 thymalfasin 61 mTOR inhibitor 61 bardoxolone 61 AEGR 61 regadenoson 61 Tyrima 61 Romidepsin 61 Aviptadil 61 elesclomol 61 Blinatumomab 61 Bronchitol 61 trastuzumab DM1 61 Reolysin 61 brentuximab vedotin 61 lapatinib Tykerb 61 Alfimeprase 61 Onalta 61 Ocrelizumab 61 bortezomib Velcade R 61 MyVax R 61 Imprime PGG 61 Amigal 61 nonsmall cell lung cancer 61 SUTENT ® 61 Iluvien 61 Campath ® 61 metastatic colorectal 61 Cethrin 61 Actilon 61 pralatrexate 61 AMD# [003] 61 Symadex 61 cetuximab Erbitux 61 ZEVALIN ® 61 Pirfenidone 61 BCX# 61 EVIZON TM 61 generation purine nucleoside 61 erlotinib Tarceva ® 61 Phase IIIb 61 Genasense 61 topical ophthalmic 61 Treanda 61 Medidur 61 PF # [002] 61 Phase Ib study 61 Zometa zoledronic acid 61 Guanilib 61 Muraglitazar 61 Sorafenib 61 velafermin 61 Perifosine 61 Relovair 61 GRN# 61 Satraplatin 61 Immunogen 61 chimeric monoclonal antibody 61 Phase IIb trial 61 Microplasmin 61 ALN PCS 61 Ophthotech 61 tolevamer 61 Tarvacin TM 61 pradefovir 61 Phase 2b clinical 61 Cloretazine 61 Macugen 61 Tofacitinib 61 dose escalation Phase 61 LBH# 61 Panzem R 61 CD# antibody [001] 61 HGS ETR1 61 NP2 Enkephalin 61 Rituxan rituximab 61 Boceprevir 61 Cladribine 61 temsirolimus 61 LUCENTIS 61 Virulizin R 61 ThermoDox ® 61 epothilone 61 Taxotere ® 61 kinase inhibitor 61 Phase IIb 61 ONCONASE R 61 Pegintron 61 ularitide 61 confirmatory Phase III 61 OncoGel 61 Phase 1b trial 61 tezampanel 61 DU #b 61 TASKi3 61 Viramidine 61 NexACT 61 Curaxin 61 Pivotal Phase III 61 tremelimumab 61 SARMs 61 nucleoside analog 61 pivotal Phase III 61 StaphVAX 61 oral ridaforolimus 61 custirsen 61 Aurora kinase 61 Jevtana 61 TNFerade 61 teplizumab 61 lomitapide 61 cathepsin K inhibitor 61 MBP# [001] 61 Phase IIa clinical 61 Fibrillex TM 61 Phase 2a 61 Pivotal Phase 61 Roche Actemra 61 Dacogen decitabine 61 figitumumab 61 PrevOnco 61 Syncria 61 fostamatinib 61 Privigen 61 phase IIb trial 61 MyVax 61 Phase IIB 61 ELND# 61 THALOMID 61 PTK ZK 61 anticancer therapy 61 Amgen Vectibix 61 Deforolimus 61 multicenter Phase II 61 Sapacitabine 61 TELCYTA 61 relapsed multiple myeloma 60 Medidur FA 60 EOquin 60 Tavocept 60 IRESSA 60 TOCOSOL Paclitaxel 60 Affinitak 60 ruxolitinib 60 Diabetic Macular Edema DME 60 Alemtuzumab 60 Cetrorelix 60 Pemetrexed 60 Phase #b/#a clinical 60 XmAb# 60 Sutent sunitinib 60 Removab 60 mapatumumab 60 RhuDex ® 60 apaziquone 60 OncoVEX GM CSF 60 valopicitabine 60 Doxil 60 perifosine 60 ImClone Erbitux 60 OZURDEX ® 60 denufosol tetrasodium 60 Kahalalide F 60 Xerecept 60 panitumumab Vectibix 60 DPP4 60 Behcet uveitis 60 GGF2 60 PEGylated interferon 60 MGd 60 EVIZON TM squalamine lactate 60 ATL# [002] 60 forodesine 60 ILUVIEN ® 60 GSK# [001] 60 Davanat 60 Voreloxin 60 SNT MC# 60 pan HDAC inhibitor 60 Shigamabs ® 60 Insegia 60 Exelixis XL# 60 ONGLYZA ™ 60 Bortezomib 60 EOquin TM 60 IMC #B 60 Ethyol 60 danoprevir 60 Xinlay 60 Alzhemed TM 60 Virulizin ® 60 midstage trials 60 ESBA# 60 zileuton CR 60 midstage clinical 60 Ranibizumab 60 JAK inhibitors 60 Laquinimod 60 Elagolix 60 SAR# [002] 60 evaluating tivozanib 60 Fabry Disease 60 Orazol 60 chemotherapeutic regimen 60 ThermoDox R 60 Vorinostat 60 Catena ® 60 OXi# 60 Olaparib 60 docetaxel chemotherapy 60 RELOVAIR ™ 60 Diabetic Macular Edema 60 Debio 60 ocular formulation 60 Epratuzumab 60 ancrod 60 Phase III trials 60 DPX Survivac 60 Nuvion 60 cetuximab Erbitux R 60 thalidomide Thalomid 60 orally bioavailable 60 PS# [001] 60 Erlotinib 60 Telavancin 60 pegylated interferons 60 RhuDex 60 interferon gamma 1b 60 Friedreich Ataxia FRDA 60 dalbavancin 60 Omnitarg 60 trabectedin 60 Pazopanib 60 Androxal TM 60 Eculizumab 60 Degarelix 60 GAMMAGARD 60 humanized monoclonal antibody 60 Rasagiline 60 IMC A# 60 almorexant 60 antiangiogenic agents 60 vilazodone 60 Aliskiren 60 investigational compound 60 MYDICAR 60 MLN# 60 Thiarabine 60 intranasal formulation 60 DYNEPO 60 Thrombin 60 Aurexis 60 Stimuvax R 60 Fanapt iloperidone 60 TLR9 agonists 60 ADVEXIN 60 Hsp# Inhibitor 60 LUVENIQ 60 ORENCIA R 60 diabetic macular edema 60 PEGylated 60 TBC# 60 Atrasentan 60 glucokinase activator 60 Opexa 60 etanercept Enbrel 60 Phase IIb clinical 60 linaclotide 60 OMNARIS HFA 60 XYOTAX TM 60 OncoVex 60 Alpharadin 60 Denufosol 60 ALN VSP 60 ketolide antibiotic 60 vorinostat 60 oral deforolimus 60 small molecule tyrosine 60 Phase III Pivotal 60 Rebif ® 60 Cimzia ® certolizumab pegol 60 Ceplene/IL-2 60 recombinant factor VIIa 60 Edoxaban 60 rxRNA 60 Gleevec imatinib mesylate 60 palifosfamide 60 Prodarsan ® 60 vemurafenib 60 romidepsin 60 renin inhibitors 60 afatinib 60 vismodegib 60 Pixantrone 60 MEK inhibitors 60 LymphoStat B TM 60 EP #R 60 Allovectin 7 R 60 HER2 positive metastatic breast 60 Cogane 60 PEG PAL 60 Enzastaurin 60 tubulin inhibitor 60 tyrosine kinase inhibitor 60 ONTAK 60 Proxinium TM 60 NGX# 60 DAVANAT 60 ecabet sodium 60 voreloxin 60 aflibercept VEGF Trap 60 JAK Inhibitor 60 diarrhea predominant irritable 60 UVIDEM 60 indibulin 60 bicifadine 60 MORAb 60 AVE# 60 Romiplostim 60 WILEX 60 Inhalation Solution 60 Revlimid lenalidomide 60 lorvotuzumab mertansine 60 Phase 2a trial 60 Homspera 60 Ziopharm 60 Fx #A 60 Pivotal Trial 60 preclinical studies 60 myelofibrosis polycythemia vera 60 BEMA TM Fentanyl 60 Initiate Phase 60 cancer immunotherapies 60 Noxafil 60 diabetic macular edema DME 60 Specifid 60 MKC# MKC# PP 60 PREOS 60 MGCD# [001] 60 Plenaxis TM 60 R sorafenib tablets 60 NXL# 60 omecamtiv mecarbil 60 Telcyta 60 VNP#M 59 FoldRx 59 Zarnestra 59 Bendamustine 59 Phase III Clinical Trial 59 Rasilez 59 Genentech Roche Chugai 59 therapeutic monoclonal antibodies 59 HyperAcute 59 TNF alpha inhibitor 59 Amplimexon 59 Promacta 59 Tasigna nilotinib 59 molecularly targeted 59 Xcytrin 59 RAPTIVA R 59 OMP #M# 59 Visudyne R 59 Milnacipran 59 Tolerx 59 MAXY VII 59 standard chemotherapy regimen 59 tesetaxel 59 Annamycin 59 OvaRex R 59 Protexia R 59 TLK# 59 Gemzar ® 59 recurrent glioblastoma multiforme 59 severe hypercholesterolemia 59 maribavir 59 Elvitegravir 59 humanized anti 59 PARP inhibitor 59 nitric oxide donating prostaglandin 59 Actimmune ® 59 nucleotide analogue 59 Pivotal Study 59 isoform selective 59 Raptiva ® 59 OvaRex ® MAb 59 talactoferrin 59 MNTX 59 Telatinib 59 Soliris eculizumab 59 Nanobody ® 59 terlipressin 59 Ceplene 59 Fusilev 59 Trastuzumab DM1 59 radiation sensitizer 59 Apaziquone 59 Phase IIb trials 59 GTC recombinant human 59 MAGE A3 ASCI 59 Zelrix 59 Eltrombopag 59 Traficet EN 59 Iloperidone 59 Initiated Phase 59 ATryn R 59 tasocitinib 59 Bayer Nexavar 59 anti CD# antibodies 59 Phase III 59 GV# [001] 59 oral gallium 59 HSP# inhibitor 59 Glatiramer Acetate 59 Phase III clinical trials 59 IV Busulfex 59 Besivance 59 Phase #b/#a trial 59 MDV# 59 Topotecan 59 Folotyn 59 oral salmon calcitonin 59 Olmesartan 59 calcineurin inhibitors 59 Thalomid thalidomide 59 INCB# [002] 59 Evoltra 59 Vascular Endothelial Growth 59 hA# 59 Azixa 59 IAP inhibitor 59 Ontak 59 humanized antibody 59 ATL/TV# 59 PKC# 59 Anti VEGF 59 MAb 59 Crizotinib 59 Genasense ® 59 Arranon 59 KRN# 59 Saforis 59 immunomodulator 59 lenalidomide Revlimid 59 Bayer Onyx 59 Prolacria 59 Cancidas 59 INTEGRILIN 59 phase IIb study 59 Tocosol Paclitaxel 59 NEBIDO 59 PROSTVAC TM 59 GVAX 59 anticancer compound 59 TG# [001] 59 indolent NHL 59 Gemzar gemcitabine 59 #D#C# 59 telaprevir VX 59 Clofarabine 59 registrational trial 59 IIa trial 59 Kyowa Hakko Kirin 59 Talabostat 59 bafetinib 59 TH# [003] 59 RGB # 59 ASONEP TM 59 NU# [001] 59 orBec 59 BCR ABL inhibitors 59 PEG INTRON 59 HIV protease inhibitors 59 Spiegelmer ® 59 Phase 1b clinical 59 cabozantinib 59 Initiate Clinical Trial 59 ulimorelin 59 Proleukin 59 Phase 2b trial 59 BRIM2 59 Belinostat 59 APTIVUS 59 pain palliation 59 TRO# 59 MGCD# [002] 59 Sanofi Aventis Taxotere 59 NPC 1C 59 riociguat 59 Saxagliptin 59 farletuzumab 59 Virulizin 59 EGS# 59 Erbitux 59 SUCCEED trial 59 AZILECT ® 59 bendamustine 59 prostone 59 CIMZIA TM 59 CCR9 antagonist 59 acetonide FA 59 ProLindac 59 YONDELIS R 59 vascular disrupting agents 59 QVA# 59 Cimzia TM 59 monoclonal antibody 59 PNP inhibitor 59 tesmilifene 59 PegIntron 59 TroVax ® 59 zanolimumab 59 XL# [003] 59 Cinquil 59 NV1FGF 59 PRTX 59 ThGRF 59 nab paclitaxel 59 ZACTIMA 59 R#/MEM 59 refractory chronic lymphocytic 59 Tanezumab 59 DOS# 59 ostarine 59 DermaVir Patch 59 LUX Lung 59 velafermin belinostat 59 CYT# potent vascular disrupting 59 biodegradable implant 59 EyeGate 59 novel VDA molecule 59 Genentech Rituxan 59 fosbretabulin 59 Actemra tocilizumab 59 diquafosol tetrasodium 59 Campath 59 BrachySil 59 anidulafungin 59 JAK3 59 diabetic neuropathic pain 59 entinostat 59 Vorapaxar 59 oral cladribine 59 LEP ETU 59 AzaSite 59 seliciclib CYC# 59 GSK# [002] 59 OMP #R# 59 Rituximab 59 Combidex 59 LE DT 59 Relistor 59 torcetrapib atorvastatin 59 amrubicin 59 Octreolin 59 subcutaneously administered 59 EndoTAGTM 1 59 Phase #/#a trial 59 Mycamine 59 ocular hypertension 59 multitargeted 59 motesanib 59 TLR agonists 59 adecatumumab MT# 59 timolol 59 Linaclotide 59 anti VEGF 59 EGFr 59 ANYARA 59 Aerosurf 59 selective S#P# receptor agonist 59 Alvesco R 59 Phase Ia 59 Chemophase 59 Pralatrexate 59 Solazed TM 59 Kuvan 59 Rotigotine 59 Regeneron 59 Emselex 59 tiapamil 59 UPLYSO 59 placebo controlled clinical 59 alemtuzumab Campath 59 lixisenatide 59 LymphoStat B 59 Azacitidine 59 gastro intestinal inflammation 59 bevacizumab Avastin ® 59 Exelixis compounds 59 Taxol paclitaxel 59 GED aPC 59 preclinically 59 Diamyd ® 59 RPL# 59 capecitabine Xeloda R 59 enoximone 59 CD# monoclonal antibody 59 PhosLo 59 clinical trial 59 Iluvien ® 59 ITAX 59 Nexavar sorafenib tablets 59 Ereska 59 ACZ# 59 paclitaxel Taxol 59 pazopanib 59 Torisel 59 Stedivaze 59 Tanespimycin 59 SinuNase 59 Hepatocellular Carcinoma HCC 59 Stimuvax 59 Novolimus 59 VEGF inhibitors 59 alvimopan 59 BZL# 59 Solzira 59 docetaxel Taxotere 59 Antiangiogenic 59 huN# DM1 58 trastuzumab Herceptin 58 HDACi 58 Phase Ib IIa 58 Lu AA# 58 Neuradiab 58 Roche Pegasys 58 Loramyc 58 Prodarsan R 58 Meets Primary Endpoint 58 tiuxetan 58 TASKi2 58 Medidur TM 58 hypoxia activated prodrug 58 daptomycin 58 Lixivaptan 58 BENLYSTA ® 58 NDA submission 58 Intravitreal 58 Triolex 58 Telintra 58 ISTODAX 58 solanezumab 58 Randomized Phase 58 dasatinib Sprycel 58 Ostarine 58 PD LID 58 sunitinib Sutent 58 vinca alkaloid 58 Abraxane 58 Phase IIa clinical trials 58 MabThera Rituxan 58 antisense oligonucleotide 58 Temsirolimus 58 Indaflex TM 58 confirmatory Phase 3 58 HspE7 58 CYT# QbG# 58 verteporfin 58 ospemifene 58 baminercept 58 ponatinib 58 TRV# [001] 58 Phase 2b study 58 Copegus ribavirin 58 CLORETAZINE TM VNP#M 58 thetreatment 58 Teysuno 58 ABRAXANE ® 58 Sprycel 58 Eribulin 58 Apixaban 58 lesinurad 58 Urocidin

Back to home page